Moreover, our study showed the Hylach 1 and Hylach 2 downregulation of Smad2 expression, supporting the hypothesis that Hylach compounds inhibit the TGF-β/SMAD signaling pathway, the main recognized pro-fibrogenic pathway in IPF. This evidence concerns the gene SMAD2 and idiopathic pulmonary fibrosis.